✦ LIBER ✦

466 HCV core Ag as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alfa-2B plus ribavirin

✍ Scribed by M. Buti; A. Valdes; C. Mendez; M. Schaper; S. Sauleda; F. Rodriguez-Frias; R. Jardi; R. Esteban; J. Guardia

Book ID: 117373294
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 60 KB
Volume: 40
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(04)90466-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C virus Core Antigen as a pred

Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin

✍ Maria Buti; Claudia Mendez; Melanie Schaper; Silvia Sauleda; Auristela Valdes; F 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 332 KB

466 PREDICTORS OF SUSTAINED VIROLOGIC RE

466 PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE AMONG TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 WHEN TREATED WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN (PR)

✍ K.R. Reddy; S. Bruno; L. Rossaro; N. Ravendhran; M.P. Pauly; N. Boparai; V. Sniu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Peginterferon alfa-2b plus ribavirin for

Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3

✍ Stefan Zeuzem; Rolf Hultcrantz; Marc Bourliere; Tobias Goeser; Patrick Marcellin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 220 KB

PIN92 Patient Reported Outcomes Among Ch

PIN92 Patient Reported Outcomes Among Chronic Hepatitis C Patients Re-Treated with Peginterferon Alfa-2A/Ribavirin After Non-response to Peginterferon Alfa-2B/Ribavirin in Spain

✍ A. Olveira; D. Rincon; M. Diago; J. Crespo; J.L. Calleja; J. Salmeron; R. Andrad 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Viral kinetics in genotype 1 chronic hep

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

✍ Maria Buti; Francisco Sanchez-Avila; Yoav Lurie; Carlos Stalgis; Auristela Valdé 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

Prediction of response to peginterferon-

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b

✍ Yoshimasa Hashimoto; Hidenori Ochi; Hiromi Abe; Yasufumi Hayashida; Masataka Tsu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v